Ibio Inc (IBIO)
Drugs • Health Care
Percentage
Change
| Oct 12 | Sep 13 | Sep 14 | Oct 15 | Oct 16 | Sep 17 | Sep 18 | Aug 19 | Oct 20 | Sep 21 | Oct 22 | Sep 23 | Sep 24 | Sep 25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -25 | -18 | ||||||||||||
Net Income | -25 | -18 | ||||||||||||
Profit | -25 | -18 | ||||||||||||
Net Income Discontinued | -9 | 0 | ||||||||||||
Net Income Continuing | -15 | -18 | ||||||||||||
Pretax Income | -15 | -18 | ||||||||||||
Total Non-operating Income | 1 | 0 | ||||||||||||
Operating Income | -17 | -19 | ||||||||||||
Total Revenue | 0 | 0 | ||||||||||||
Total Costs and Expenses | -17 | -19 | ||||||||||||
Operating Expenses | -17 | -19 | ||||||||||||
Research and Development Expenses | -5 | -8 | ||||||||||||
Selling, General & Administrative Expenses | -12 | -11 |